Archives: Speakers

Paul has 28 years’ experience working in Life Sciences; 7 researching Respiratory indications (asthma, COPD, PPH) and 9 years in Clinical Research for emerging Biotechs managing programs in across Respiratory, Oncology, Gastro-Enterology, Endocrinology therapeutic areas. Over the last 12 years Paul has specialised in eClinical, working for CROs and technology providers with a focus on clinical trial processes, ICH GCP, the use of technology to solve industry problems, and is also an SME in RBQM.

Ursina Lüthi has been Chief Product Officer at ECOFIN Software and Technology AG – the Finfox company – since 2020. She joined ECOFIN in 1995, held various leading positions within the firm and has been a member of the Executive Board since 2002. Ursina is the mastermind of Finfox, having been in charge of the solution and its continuous development since the very beginning in 2007. Over the last 25 years she has gained deep expertise in product development, product strategy and consulting in the area of wealth advisory services. Ursina graduated in Business and Economics from the University of Zurich. She is fluent in five languages including her mother tongue Rhaeto-Romanic.

Matt is head of architecture and strategy, developing the future Technology strategy for Whitbread, covering a major period of investment in our core technology to help prepare the business for the accelerating demand for digital services and further growth, both in the UK and beyond. 

Focusing on finding new opportunities to collaborate and utilise existing technologies across Premier Inn and restaurants.

Sascha held numerous positions in business development and operations, most notably in global Commercial Operations AMERICAS & EMEA at Marken and VP Business Development at Sharp Clinical Services, where he formed a new business development team and implemented novel services. Sascha is a subject matter expert of a broad range of services along the clinical supply chain such as Direct-to-Patient, labelling & packaging, cell & gene therapies , and global distribution strategies. Sascha studied economics and holds a MBA in International Management and Leadership. He has been a long-term member of the ISPE Investigational Product community, contributed to the development of several Good Practice Guides and was a member of the European IP Steering Committee. At SanaClis Sascha is leading global business development and acts as Country Head Germany.